0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Shield Minimally Invasive Fascial Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-35Z17294
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Shield Minimally Invasive Fascial Closure Device Market Research Report 2024
BUY CHAPTERS

Global Shield Minimally Invasive Fascial Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-35Z17294
Report
October 2025
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Shield Minimally Invasive Fascial Closure Device Market

The global Shield Minimally Invasive Fascial Closure Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The Shield Minimally Invasive Fascial Closure Device is a specialized surgical instrument designed to facilitate the closure of fascial layers following minimally invasive procedures.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Shield Minimally Invasive Fascial Closure Device leading manufacturers including Teleflex, Medtronic, CooperSurgical, Shandong Bainus Medical Instrumen, Golden Stapler Surgical, Suture Ease, EndoSystem, Weipu Medical, Longmed, Aofo, etc., dominate supply; the top five capture approximately % of global revenue, with Teleflex leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Shield Minimally Invasive Fascial Closure Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Shield Minimally Invasive Fascial Closure Device Market Report

Report Metric Details
Report Name Shield Minimally Invasive Fascial Closure Device Market
Segment by Type
  • Shell Diameter 10mm-13mm
  • Shell Diameter 13mm-16mm
  • Shell Diameter 16mm or More
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teleflex, Medtronic, CooperSurgical, Shandong Bainus Medical Instrumen, Golden Stapler Surgical, Suture Ease, EndoSystem, Weipu Medical, Longmed, Aofo, Double Medical Technology, Dongfeng Yihe, WODELIPAI, Portoria Medical, Anrei Sinolinrs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Shield Minimally Invasive Fascial Closure Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Shield Minimally Invasive Fascial Closure Device Market report?

Ans: The main players in the Shield Minimally Invasive Fascial Closure Device Market are Teleflex, Medtronic, CooperSurgical, Shandong Bainus Medical Instrumen, Golden Stapler Surgical, Suture Ease, EndoSystem, Weipu Medical, Longmed, Aofo, Double Medical Technology, Dongfeng Yihe, WODELIPAI, Portoria Medical, Anrei Sinolinrs

What are the Application segmentation covered in the Shield Minimally Invasive Fascial Closure Device Market report?

Ans: The Applications covered in the Shield Minimally Invasive Fascial Closure Device Market report are Hospital, Clinic

What are the Type segmentation covered in the Shield Minimally Invasive Fascial Closure Device Market report?

Ans: The Types covered in the Shield Minimally Invasive Fascial Closure Device Market report are Shell Diameter 10mm-13mm, Shell Diameter 13mm-16mm, Shell Diameter 16mm or More

Recommended Reports

Minimally Invasive Devices

Surgical Closure Products

Protective Surgical Solutions

1 Study Coverage
1.1 Introduction to Shield Minimally Invasive Fascial Closure Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Shield Minimally Invasive Fascial Closure Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Shell Diameter 10mm-13mm
1.2.3 Shell Diameter 13mm-16mm
1.2.4 Shell Diameter 16mm or More
1.3 Market Segmentation by Application
1.3.1 Global Shield Minimally Invasive Fascial Closure Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Shield Minimally Invasive Fascial Closure Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Estimates and Forecasts 2020-2031
2.4 Global Shield Minimally Invasive Fascial Closure Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Shield Minimally Invasive Fascial Closure Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Shell Diameter 10mm-13mm Market Size by Manufacturers
3.5.2 Shell Diameter 13mm-16mm Market Size by Manufacturers
3.5.3 Shell Diameter 16mm or More Market Size by Manufacturers
3.6 Global Shield Minimally Invasive Fascial Closure Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Shield Minimally Invasive Fascial Closure Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Shield Minimally Invasive Fascial Closure Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Type (2020-2031)
6.4 North America Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Shield Minimally Invasive Fascial Closure Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Type (2020-2031)
7.4 Europe Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Shield Minimally Invasive Fascial Closure Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Shield Minimally Invasive Fascial Closure Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Shield Minimally Invasive Fascial Closure Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Teleflex
11.1.1 Teleflex Corporation Information
11.1.2 Teleflex Business Overview
11.1.3 Teleflex Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.1.4 Teleflex Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Teleflex Shield Minimally Invasive Fascial Closure Device Sales by Product in 2024
11.1.6 Teleflex Shield Minimally Invasive Fascial Closure Device Sales by Application in 2024
11.1.7 Teleflex Shield Minimally Invasive Fascial Closure Device Sales by Geographic Area in 2024
11.1.8 Teleflex Shield Minimally Invasive Fascial Closure Device SWOT Analysis
11.1.9 Teleflex Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.2.4 Medtronic Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Shield Minimally Invasive Fascial Closure Device Sales by Product in 2024
11.2.6 Medtronic Shield Minimally Invasive Fascial Closure Device Sales by Application in 2024
11.2.7 Medtronic Shield Minimally Invasive Fascial Closure Device Sales by Geographic Area in 2024
11.2.8 Medtronic Shield Minimally Invasive Fascial Closure Device SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 CooperSurgical
11.3.1 CooperSurgical Corporation Information
11.3.2 CooperSurgical Business Overview
11.3.3 CooperSurgical Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.3.4 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales by Product in 2024
11.3.6 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales by Application in 2024
11.3.7 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales by Geographic Area in 2024
11.3.8 CooperSurgical Shield Minimally Invasive Fascial Closure Device SWOT Analysis
11.3.9 CooperSurgical Recent Developments
11.4 Shandong Bainus Medical Instrumen
11.4.1 Shandong Bainus Medical Instrumen Corporation Information
11.4.2 Shandong Bainus Medical Instrumen Business Overview
11.4.3 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.4.4 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales by Product in 2024
11.4.6 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales by Application in 2024
11.4.7 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales by Geographic Area in 2024
11.4.8 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device SWOT Analysis
11.4.9 Shandong Bainus Medical Instrumen Recent Developments
11.5 Golden Stapler Surgical
11.5.1 Golden Stapler Surgical Corporation Information
11.5.2 Golden Stapler Surgical Business Overview
11.5.3 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.5.4 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales by Product in 2024
11.5.6 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales by Application in 2024
11.5.7 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales by Geographic Area in 2024
11.5.8 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device SWOT Analysis
11.5.9 Golden Stapler Surgical Recent Developments
11.6 Suture Ease
11.6.1 Suture Ease Corporation Information
11.6.2 Suture Ease Business Overview
11.6.3 Suture Ease Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.6.4 Suture Ease Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Suture Ease Recent Developments
11.7 EndoSystem
11.7.1 EndoSystem Corporation Information
11.7.2 EndoSystem Business Overview
11.7.3 EndoSystem Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.7.4 EndoSystem Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 EndoSystem Recent Developments
11.8 Weipu Medical
11.8.1 Weipu Medical Corporation Information
11.8.2 Weipu Medical Business Overview
11.8.3 Weipu Medical Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.8.4 Weipu Medical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Weipu Medical Recent Developments
11.9 Longmed
11.9.1 Longmed Corporation Information
11.9.2 Longmed Business Overview
11.9.3 Longmed Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.9.4 Longmed Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Longmed Recent Developments
11.10 Aofo
11.10.1 Aofo Corporation Information
11.10.2 Aofo Business Overview
11.10.3 Aofo Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.10.4 Aofo Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Aofo Recent Developments
11.11 Double Medical Technology
11.11.1 Double Medical Technology Corporation Information
11.11.2 Double Medical Technology Business Overview
11.11.3 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.11.4 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Double Medical Technology Recent Developments
11.12 Dongfeng Yihe
11.12.1 Dongfeng Yihe Corporation Information
11.12.2 Dongfeng Yihe Business Overview
11.12.3 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.12.4 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Dongfeng Yihe Recent Developments
11.13 WODELIPAI
11.13.1 WODELIPAI Corporation Information
11.13.2 WODELIPAI Business Overview
11.13.3 WODELIPAI Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.13.4 WODELIPAI Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 WODELIPAI Recent Developments
11.14 Portoria Medical
11.14.1 Portoria Medical Corporation Information
11.14.2 Portoria Medical Business Overview
11.14.3 Portoria Medical Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.14.4 Portoria Medical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Portoria Medical Recent Developments
11.15 Anrei Sinolinrs
11.15.1 Anrei Sinolinrs Corporation Information
11.15.2 Anrei Sinolinrs Business Overview
11.15.3 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Product Models, Descriptions and Specifications
11.15.4 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Anrei Sinolinrs Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Shield Minimally Invasive Fascial Closure Device Industry Chain
12.2 Shield Minimally Invasive Fascial Closure Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Shield Minimally Invasive Fascial Closure Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Shield Minimally Invasive Fascial Closure Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Shield Minimally Invasive Fascial Closure Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Shield Minimally Invasive Fascial Closure Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Shield Minimally Invasive Fascial Closure Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Shield Minimally Invasive Fascial Closure Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Shield Minimally Invasive Fascial Closure Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Shield Minimally Invasive Fascial Closure Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Shield Minimally Invasive Fascial Closure Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2020-2025) & (K Units)
 Table 8. Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Shield Minimally Invasive Fascial Closure Device Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Shield Minimally Invasive Fascial Closure Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Shield Minimally Invasive Fascial Closure Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Shield Minimally Invasive Fascial Closure Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shield Minimally Invasive Fascial Closure Device as of 2024)
 Table 16. Global Shield Minimally Invasive Fascial Closure Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Shield Minimally Invasive Fascial Closure Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Shield Minimally Invasive Fascial Closure Device Manufacturing Base and Headquarters
 Table 19. Global Shield Minimally Invasive Fascial Closure Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Shield Minimally Invasive Fascial Closure Device Sales by Type (2020-2025) & (K Units)
 Table 23. Global Shield Minimally Invasive Fascial Closure Device Sales by Type (2026-2031) & (K Units)
 Table 24. Global Shield Minimally Invasive Fascial Closure Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Shield Minimally Invasive Fascial Closure Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Shield Minimally Invasive Fascial Closure Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Shield Minimally Invasive Fascial Closure Device Sales by Application (2020-2025) & (K Units)
 Table 29. Global Shield Minimally Invasive Fascial Closure Device Sales by Application (2026-2031) & (K Units)
 Table 30. Shield Minimally Invasive Fascial Closure Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Shield Minimally Invasive Fascial Closure Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Shield Minimally Invasive Fascial Closure Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Shield Minimally Invasive Fascial Closure Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Shield Minimally Invasive Fascial Closure Device Growth Accelerators and Market Barriers
 Table 37. North America Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Shield Minimally Invasive Fascial Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Shield Minimally Invasive Fascial Closure Device Growth Accelerators and Market Barriers
 Table 40. Europe Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Shield Minimally Invasive Fascial Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Shield Minimally Invasive Fascial Closure Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Teleflex Corporation Information
 Table 51. Teleflex Description and Major Businesses
 Table 52. Teleflex Product Models, Descriptions and Specifications
 Table 53. Teleflex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Teleflex Sales Value Proportion by Product in 2024
 Table 55. Teleflex Sales Value Proportion by Application in 2024
 Table 56. Teleflex Sales Value Proportion by Geographic Area in 2024
 Table 57. Teleflex Shield Minimally Invasive Fascial Closure Device SWOT Analysis
 Table 58. Teleflex Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Shield Minimally Invasive Fascial Closure Device SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. CooperSurgical Corporation Information
 Table 69. CooperSurgical Description and Major Businesses
 Table 70. CooperSurgical Product Models, Descriptions and Specifications
 Table 71. CooperSurgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. CooperSurgical Sales Value Proportion by Product in 2024
 Table 73. CooperSurgical Sales Value Proportion by Application in 2024
 Table 74. CooperSurgical Sales Value Proportion by Geographic Area in 2024
 Table 75. CooperSurgical Shield Minimally Invasive Fascial Closure Device SWOT Analysis
 Table 76. CooperSurgical Recent Developments
 Table 77. Shandong Bainus Medical Instrumen Corporation Information
 Table 78. Shandong Bainus Medical Instrumen Description and Major Businesses
 Table 79. Shandong Bainus Medical Instrumen Product Models, Descriptions and Specifications
 Table 80. Shandong Bainus Medical Instrumen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Shandong Bainus Medical Instrumen Sales Value Proportion by Product in 2024
 Table 82. Shandong Bainus Medical Instrumen Sales Value Proportion by Application in 2024
 Table 83. Shandong Bainus Medical Instrumen Sales Value Proportion by Geographic Area in 2024
 Table 84. Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device SWOT Analysis
 Table 85. Shandong Bainus Medical Instrumen Recent Developments
 Table 86. Golden Stapler Surgical Corporation Information
 Table 87. Golden Stapler Surgical Description and Major Businesses
 Table 88. Golden Stapler Surgical Product Models, Descriptions and Specifications
 Table 89. Golden Stapler Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Golden Stapler Surgical Sales Value Proportion by Product in 2024
 Table 91. Golden Stapler Surgical Sales Value Proportion by Application in 2024
 Table 92. Golden Stapler Surgical Sales Value Proportion by Geographic Area in 2024
 Table 93. Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device SWOT Analysis
 Table 94. Golden Stapler Surgical Recent Developments
 Table 95. Suture Ease Corporation Information
 Table 96. Suture Ease Description and Major Businesses
 Table 97. Suture Ease Product Models, Descriptions and Specifications
 Table 98. Suture Ease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Suture Ease Recent Developments
 Table 100. EndoSystem Corporation Information
 Table 101. EndoSystem Description and Major Businesses
 Table 102. EndoSystem Product Models, Descriptions and Specifications
 Table 103. EndoSystem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. EndoSystem Recent Developments
 Table 105. Weipu Medical Corporation Information
 Table 106. Weipu Medical Description and Major Businesses
 Table 107. Weipu Medical Product Models, Descriptions and Specifications
 Table 108. Weipu Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Weipu Medical Recent Developments
 Table 110. Longmed Corporation Information
 Table 111. Longmed Description and Major Businesses
 Table 112. Longmed Product Models, Descriptions and Specifications
 Table 113. Longmed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Longmed Recent Developments
 Table 115. Aofo Corporation Information
 Table 116. Aofo Description and Major Businesses
 Table 117. Aofo Product Models, Descriptions and Specifications
 Table 118. Aofo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Aofo Recent Developments
 Table 120. Double Medical Technology Corporation Information
 Table 121. Double Medical Technology Description and Major Businesses
 Table 122. Double Medical Technology Product Models, Descriptions and Specifications
 Table 123. Double Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Double Medical Technology Recent Developments
 Table 125. Dongfeng Yihe Corporation Information
 Table 126. Dongfeng Yihe Description and Major Businesses
 Table 127. Dongfeng Yihe Product Models, Descriptions and Specifications
 Table 128. Dongfeng Yihe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Dongfeng Yihe Recent Developments
 Table 130. WODELIPAI Corporation Information
 Table 131. WODELIPAI Description and Major Businesses
 Table 132. WODELIPAI Product Models, Descriptions and Specifications
 Table 133. WODELIPAI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. WODELIPAI Recent Developments
 Table 135. Portoria Medical Corporation Information
 Table 136. Portoria Medical Description and Major Businesses
 Table 137. Portoria Medical Product Models, Descriptions and Specifications
 Table 138. Portoria Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Portoria Medical Recent Developments
 Table 140. Anrei Sinolinrs Corporation Information
 Table 141. Anrei Sinolinrs Description and Major Businesses
 Table 142. Anrei Sinolinrs Product Models, Descriptions and Specifications
 Table 143. Anrei Sinolinrs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Anrei Sinolinrs Recent Developments
 Table 145. Key Raw Materials Distribution
 Table 146. Raw Materials Key Suppliers
 Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 148. Milestones in Production Technology Evolution
 Table 149. Distributors List
 Table 150. Market Trends and Market Evolution
 Table 151. Market Drivers and Opportunities
 Table 152. Market Challenges, Risks, and Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources


List of Figures
 Figure 1. Shield Minimally Invasive Fascial Closure Device Product Picture
 Figure 2. Global Shield Minimally Invasive Fascial Closure Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Shell Diameter 10mm-13mm Product Picture
 Figure 4. Shell Diameter 13mm-16mm Product Picture
 Figure 5. Shell Diameter 16mm or More Product Picture
 Figure 6. Global Shield Minimally Invasive Fascial Closure Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Shield Minimally Invasive Fascial Closure Device Report Years Considered
 Figure 10. Global Shield Minimally Invasive Fascial Closure Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Shield Minimally Invasive Fascial Closure Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Region (2020-2031)
 Figure 14. Global Shield Minimally Invasive Fascial Closure Device Sales (2020-2031) & (K Units)
 Figure 15. Global Shield Minimally Invasive Fascial Closure Device Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Volume Market Share in 2024
 Figure 18. Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Shell Diameter 10mm-13mm Revenue Market Share by Manufacturer in 2024
 Figure 21. Shell Diameter 13mm-16mm Revenue Market Share by Manufacturer in 2024
 Figure 22. Shell Diameter 16mm or More Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Type (2020-2031)
 Figure 24. Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Type (2020-2031)
 Figure 25. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Application (2020-2031)
 Figure 26. Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Application (2020-2031)
 Figure 27. North America Shield Minimally Invasive Fascial Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Shield Minimally Invasive Fascial Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) in 2024
 Figure 30. North America Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Shield Minimally Invasive Fascial Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Shield Minimally Invasive Fascial Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 45. France Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 60. India Shield Minimally Invasive Fascial Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Shield Minimally Invasive Fascial Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Shield Minimally Invasive Fascial Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Shield Minimally Invasive Fascial Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Shield Minimally Invasive Fascial Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 81. Shield Minimally Invasive Fascial Closure Device Industry Chain Mapping
 Figure 82. Regional Shield Minimally Invasive Fascial Closure Device Manufacturing Base Distribution (%)
 Figure 83. Global Shield Minimally Invasive Fascial Closure Device Production Market Share by Region (2020-2031)
 Figure 84. Shield Minimally Invasive Fascial Closure Device Production Process
 Figure 85. Regional Shield Minimally Invasive Fascial Closure Device Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network